jili slot online casino
Demi Moore gives emotional update on Bruce Willis' as he continue to battle dementiaPrincipal U.S. Small-Cap Multi-Factor ETF ( NASDAQ:PSC – Get Free Report ) saw unusually-high trading volume on Friday after the company announced a dividend. Approximately 103,351 shares changed hands during trading, an increase of 255% from the previous session’s volume of 29,146 shares.The stock last traded at $51.52 and had previously closed at $52.49. The newly announced dividend which will be paid on Tuesday, December 31st. Stockholders of record on Friday, December 27th will be given a $0.0795 dividend. The ex-dividend date of this dividend is Friday, December 27th. Principal U.S. Small-Cap Multi-Factor ETF Stock Performance The firm has a fifty day moving average of $53.69 and a 200 day moving average of $51.27. The firm has a market capitalization of $668.87 million, a PE ratio of 9.54 and a beta of 1.19. Institutional Inflows and Outflows About Principal U.S. Small-Cap Multi-Factor ETF ( Get Free Report ) The Principal U.S. Small-Cap Multi-Factor ETF (PSC) is an exchange-traded fund that is based on the Russell 2000 index. The fund is actively managed to invest in small-cap US companies. The fund uses a proprietary, quantitative model to construct the portfolio. PSC was launched on Sep 21, 2016 and is managed by Principal. Recommended Stories Receive News & Ratings for Principal U.S. Small-Cap Multi-Factor ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Principal U.S. Small-Cap Multi-Factor ETF and related companies with MarketBeat.com's FREE daily email newsletter .
Sernova Corp. ( TSE:SVA – Get Free Report )’s share price reached a new 52-week low during mid-day trading on Friday . The stock traded as low as C$0.21 and last traded at C$0.22, with a volume of 196750 shares changing hands. The stock had previously closed at C$0.22. Wall Street Analysts Forecast Growth Several research firms recently commented on SVA. Ventum Cap Mkts upgraded shares of Sernova to a “strong-buy” rating in a research report on Thursday, September 12th. Ventum Financial cut their price target on shares of Sernova from C$3.00 to C$2.50 and set a “buy” rating on the stock in a report on Friday, September 13th. Finally, Leede Financial decreased their price objective on Sernova from C$3.00 to C$1.50 and set a “speculative buy” rating for the company in a report on Friday, September 13th. Read Our Latest Report on Sernova Sernova Price Performance Sernova Company Profile ( Get Free Report ) Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Further Reading Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter .
None2025 LDV Terron 9: Australian testing underway for bigger, bolder Ranger rival
None
Rein Entertainment stuns global audiences with 'Drug War: A Conspiracy of Silence' at ATF 2024
West Ham show support for hospitalized Antonio before Premier League match